-
Mashup Score: 6A rare disease program, portrayed as both lifeline and pharma handout, is set to expire - 2 hour(s) ago
Advocates for people with rare diseases say a government voucher program has been crucial to pursuing treatments. That program is due to sunset at the end of the month.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Gilead’s twice-yearly antiviral protects against HIV infection in second large trial - 3 hour(s) ago
Gilead said Thursday that its twice-yearly antiviral reduced the risk of HIV infections by 96% compared to an expected rate of infection in a second
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
After being criticized for profligate post-pandemic spending, the company is “pacing” itself to focus on launches of key medicines.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6A rare disease program, portrayed as both lifeline and pharma handout, is set to expire - 3 hour(s) ago
Advocates for people with rare diseases say a government voucher program has been crucial to pursuing treatments. That program is due to sunset at the end of the month.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Key Senate Republican throws cold water on Affordable Care Act repeal, site-neutral payment policy - 17 hour(s) ago
Bill Cassidy said any major health reforms would need to be bipartisan.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 21
Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s pipeline of next-generation candidates.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9
The first trial of a GLP-1 in children 6-12 showed it was effective, but raises questions about whether the benefits of weight loss justify giving daily medication to children so young.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 21
Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s pipeline of next-generation candidates.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Roivant acquires drug for pulmonary hypertension from Bayer - 2 day(s) ago
Roivant executives believe that mosliciguat, administered once per day using a dry powder inhaler, will help fill “an unmet medical need.”
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Roivant acquires drug for pulmonary hypertension from Bayer - 2 day(s) ago
Roivant executives believe that mosliciguat, administered once per day using a dry powder inhaler, will help fill “an unmet medical need.”
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
A rare disease voucher program, portrayed as both lifeline and pharma handout, is set to expire by @jasonmmast and @john_wilkerson https://t.co/FuvfUiXOpc via @statnews